Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-04 Sale | 2024-10-08 6:50 pm | MoonLake Immunotherapeutics | MLTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner | 2,000,000 | $50 | $100,003,200 | 1,306,753 (Indirect Direct) | View |
| 2024-10-04 Sale | 2024-10-08 4:01 pm | MoonLake Immunotherapeutics | MLTX | Sturge Simon Director | 171,000 | $53.72 | $9,186,120 | 171,980 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 7:56 pm | MoonLake Immunotherapeutics | MLTX | Santos da Silva Jorge Chief Executive Officer | 123,615 | $55.03 | $6,803,044 | 2,982,814 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 7:53 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 118,922 | $55 | $6,540,710 | 2,967,554 (Indirect Direct) | View |
| 2024-02-21 Sale | 2024-02-23 4:48 pm | MoonLake Immunotherapeutics | MLTX | Santos da Silva Jorge Chief Executive Officer | 1,125 | $55.27 | $62,179 | 3,106,429 (Direct) | View |
| 2024-02-20 Sale | 2024-02-22 6:32 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 21,078 | $57.33 | $1,208,418 | 3,086,476 (Indirect Direct) | View |
| 2024-02-15 Sale | 2024-02-20 6:36 pm | MoonLake Immunotherapeutics | MLTX | Santos da Silva Jorge Chief Executive Officer | 60,000 | $59.26 | $3,555,400 | 3,107,554 (Direct) | View |
| 2024-02-14 Sale | 2024-02-16 6:02 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 60,000 | $60.91 | $3,654,800 | 3,107,554 (Indirect Direct) | View |
| 2023-12-19 Sale | 2023-12-21 4:01 pm | MoonLake Immunotherapeutics | MLTX | Bodenstedt Matthias Chief Financial Officer | 100,000 | $59.17 | $5,917,368 | 520,903 (Direct) | View |
| 2023-10-05 Purchase | 2023-10-10 4:00 pm | MoonLake Immunotherapeutics | MLTX | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund IV LP 10% Owner | 58,839 | $59.9 | $3,524,297 | 8,494,151 (Indirect) | View |
| 2023-10-02 Purchase | 2023-10-04 5:52 pm | MoonLake Immunotherapeutics | MLTX | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund IV LP 10% Owner | 293,212 | $57.3 | $16,800,343 | 8,435,312 (Indirect) | View |
| 2023-06-30 Purchase | 2023-07-05 4:05 pm | MoonLake Immunotherapeutics | MLTX | Chen Bihua 10% Owner | 800,000 | $50 | $40,000,000 | 8,604,200 (Indirect) | View |
| 2023-06-26 Purchase | 2023-06-28 6:28 pm | MoonLake Immunotherapeutics | MLTX | Chen Bihua 10% Owner | 450,000 | $45.63 | $20,535,012 | 7,804,200 (Indirect) | View |
| 2023-03-20 Purchase | 2023-03-22 5:07 pm | MoonLake Immunotherapeutics | MLTX | Chen Bihua 10% Owner | 827,100 | $20.28 | $16,774,846 | 6,892,100 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-06 Option Award | 2024-06-10 5:06 pm | N/A 2034-06-06 | MoonLake Immunotherapeutics | MLTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner | 7,688 | $0 | 21,710,680 (Indirect) | View |
| 2024-06-06 Option Award | 2024-06-07 5:01 pm | N/A 2034-06-06 | MoonLake Immunotherapeutics | MLTX | Moukheibir Catherine Director | 7,688 | $0 | 7,688 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-07 5:00 pm | N/A 2034-06-06 | MoonLake Immunotherapeutics | MLTX | Phillips Andrew John Director | 7,688 | $0 | 7,688 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-07 5:00 pm | N/A 2034-06-06 | MoonLake Immunotherapeutics | MLTX | Xavier Ramnik Director | 7,688 | $0 | 7,688 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-07 4:59 pm | N/A 2034-06-06 | MoonLake Immunotherapeutics | MLTX | Sturge Simon Director | 7,688 | $0 | 7,688 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-07 4:58 pm | N/A 2034-06-06 | MoonLake Immunotherapeutics | MLTX | Loy Spike Director | 7,688 | $0 | 7,688 (Direct) | View |
| 2023-10-01 Conversion | 2023-10-03 7:34 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Sturge Simon Director | 353,176 | $0 | 0 (Direct) | View |
| 2023-10-01 Disposition | 2023-10-03 7:34 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Sturge Simon Director | 342,980 | $0 | 0 (Direct) | View |
| 2023-10-01 Conversion | 2023-10-03 7:30 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Bodenstedt Matthias Chief Financial Officer | 64,844 | $0 | 303,227 (Direct) | View |
| 2023-10-01 Disposition | 2023-10-03 7:30 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Bodenstedt Matthias Chief Financial Officer | 62,972 | $0 | 303,227 (Direct) | View |
| 2023-10-01 Conversion | 2023-10-03 7:28 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Santos da Silva Jorge Chief Executive Officer | 3,261,718 | $0 | 223,210 (Direct) | View |
| 2023-10-01 Disposition | 2023-10-03 7:28 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Santos da Silva Jorge Chief Executive Officer | 3,167,554 | $0 | 223,210 (Direct) | View |
| 2023-10-01 Conversion | 2023-10-03 7:27 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 2,645,842 | $0 | 202,152 (Indirect) | View |
| 2023-10-01 Disposition | 2023-10-03 7:27 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 2,569,458 | $0 | 202,152 (Indirect) | View |
| 2023-06-08 Option Award | 2023-06-12 9:11 pm | N/A 2033-06-08 | MoonLake Immunotherapeutics | MLTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner | 11,297 | $0 | 21,702,992 (Indirect) | View |
| 2023-06-08 Option Award | 2023-06-12 4:57 pm | N/A 2033-06-08 | MoonLake Immunotherapeutics | MLTX | Sturge Simon Director | 11,297 | $0 | 11,297 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:55 pm | N/A 2033-06-08 | MoonLake Immunotherapeutics | MLTX | Xavier Ramnik Director | 11,297 | $0 | 11,297 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:52 pm | N/A 2033-06-08 | MoonLake Immunotherapeutics | MLTX | Loy Spike Director | 11,297 | $0 | 11,297 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:49 pm | N/A 2033-06-08 | MoonLake Immunotherapeutics | MLTX | Moukheibir Catherine Director | 11,297 | $0 | 11,297 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:47 pm | N/A 2033-06-08 | MoonLake Immunotherapeutics | MLTX | Phillips Andrew John Director | 11,297 | $0 | 11,297 (Direct) | View |
| 2023-04-05 Conversion | 2023-04-07 4:05 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Bodenstedt Matthias Chief Financial Officer | 574,517 | $0 | 368,071 (Direct) | View |
| 2023-04-05 Disposition | 2023-04-07 4:05 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Bodenstedt Matthias Chief Financial Officer | 557,931 | $0 | 368,071 (Direct) | View |
| 2023-04-05 Conversion | 2023-04-07 4:05 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 615,876 | $0 | 2,847,994 (Indirect) | View |
| 2023-04-05 Disposition | 2023-04-07 4:05 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 598,096 | $0 | 2,847,994 (Indirect) | View |
| 2022-04-06 Option Award | 2022-05-05 5:51 pm | N/A 2032-04-06 | MoonLake Immunotherapeutics | MLTX | Sturge Simon Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-04-06 Option Award | 2022-05-05 5:49 pm | N/A 2032-04-06 | MoonLake Immunotherapeutics | MLTX | Xavier Ramnik Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-04-06 Option Award | 2022-05-05 5:47 pm | N/A 2032-04-06 | MoonLake Immunotherapeutics | MLTX | Moukheibir Catherine Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-04-06 Option Award | 2022-05-05 5:45 pm | N/A 2032-04-06 | MoonLake Immunotherapeutics | MLTX | Phillips Andrew John Director | 45,000 | $0 | 45,000 (Direct) | View |
Ownership | 2022-04-15 5:26 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner | 0 | $0 | 21,691,694 (Direct) | View |
Ownership | 2022-04-15 4:07 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 0 | $0 | 3,463,870 (Indirect) | View |
Ownership | 2022-04-15 4:07 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Santos da Silva Jorge Chief Executive Officer | 0 | $0 | 3,463,870 (Direct) | View |
Ownership | 2022-04-15 4:06 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Sturge Simon Director | 0 | $0 | 353,176 (Direct) | View |